← Latest news 
Novartis ramps up India role driving early drug research for global innovation pipeline
Entertainment
Published on 11 May 2026
Early stage trials and research now run from India
Novartis says it is expanding how India contributes to its global drug development. The company is shifting more early stage research to India while doubling down on innovative medicines. With plans to bring additional new medicines to market soon, the move signals deeper long term commitment to India’s healthcare ecosystem and its workforce.
- Novartis is moving early-stage research to India
- Company is expanding its global drug development role from India
- More innovative medicines are planned for future launches
- Strategy strengthens commitment to the Indian market and employees
Read the full story at The Economic Times
This summarization was done by Beige for a story published on 
The Economic Times